Filing Details

Accession Number:
0001225208-12-011833
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-05-10 13:00:00
Reporting Period:
2012-05-10
Filing Date:
2012-05-10
Accepted Time:
2012-05-10 15:05:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
310158 Merck & Co. Inc. MRK Pharmaceutical Preparations (2834) 221918501
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1475384 Iii S Richard Bowles One Merck Drive
Whitehouse Station NJ 08889-0100
Exe Vp&Chief Ethics & Comploff No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-05-10 27,377 $20.66 100,917 No 4 M Direct
Common Stock Disposition 2012-05-10 27,377 $38.50 73,540 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2012-05-10 27,377 $0.00 27,377 $20.66
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2009-05-01 2015-04-30 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 252 Indirect As Custodian
Common Stock - 401(K) Plan 3,753 Indirect By 401(k)
Footnotes
  1. Includes shares acquired and dividends earned through April 6, 2012 in the MSD Employee Savings and Security Plan, a 401(k) plan.